Edesa Biotech is trading at $3.62, down 7.30% in pre-market on October 6, 2026; no company-specific announcement explaining the decline was identified.
- The company’s news page lists its latest releases as dated August 19, 2026.
- Major U.S. indices were higher in the supplied market context, so the broader trend does not explain the decline.
- Pre-market volume or activity level was unavailable in the supplied information.